Giulia Binarelli

Mrs. Giulia Binarelli

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
GBGiulia Binarelli
Giulia Binarelli
FJFlorence Joly
Florence Joly
LILaure Inserm
Laure Inserm
SASophie Lefevre Arbogast
Sophie Lefevre Arbogast
MLMarie Lange
Marie Lange
Cancer-related cognitive impairment (CRCI) occurs frequently in patients living with cancer, with consequences on quality of life. Recently, research on the management of these difficulties has focused on computerized cognitive stimulation and computerized physical activity programs. This systematic review presents the state of knowledge about interventions based on computerized-cognitive stimulation and/or physical activity to reduce CRCI. The review followed the PRISMA guidelines. A search was conducted in PUBMED and Web of Science databases. Risk of bias analysis was conducted using the Rob2 tool and the quality of evidence was conducted following the GRADE approach. A total of 3776 articles were initially identified and 20 of them met the inclusion criteria. Among them, sixteen investigated computerized-cognitive stimulation and four computerized-physical activity. Most of the studies were randomized controlled trials and assessed the efficacy of a home-based intervention on objective cognition in adults with cancer. Overall, cognitive improvement was found in 11/16 computerized-cognitive stimulation studies and 2/4 computerized-physical activity studies. Cognitive stimulation or physical activity improved especially cognitive complaints, memory, and attention. These results suggest the efficacy of both computerized-cognitive stimulation and physical activity. However, we report a high risk of bias for the majority of studies and a low level of quality of evidence. Therefore, further investigations are needed to confirm the efficacy of these interventions and to investigate the possible added benefit on cognition of a combined computerized-cognitive/physical intervention.

7 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MSMélanie Dos Santos
Mélanie Dos Santos
ILIdlir Licaj
Idlir Licaj
CBCarine Bellera
Carine Bellera
LCLaurent Cany
Laurent Cany
GBGiulia Binarelli
Giulia Binarelli
FJFlorence Joly
Florence Joly
Older cancer patients are vulnerable to chemotherapy-related cognitive impairment. We prospectively evaluated cognitive impairment and its predictive factors during first-line chemotherapy in elderly cancer patients (≥70 years). Cognitive function was evaluated by the Mini-Mental State Examination (MMSE) with adjusted scores for age and sociocultural level. Multidimensional geriatric assessment was performed at baseline and during chemotherapy including the MMSE, Instrumental Activities in Daily Living (IADL), Mini-Nutritional Assessment (MNA), and the Geriatric Depression Scale (GDS15). Quality of life (QoL) was evaluated using the European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire (QLQ-C30). Of 364 patients included, 310 had two MMSE evaluations including one at baseline and were assessed. Among these patients, 86 (27.7%) had abnormal MMSE, 195 (62.9%) abnormal MNA, 223 (71.9%) abnormal IADL, and 137 (43.1%) had depressive symptoms at baseline. MMSE impairment during chemotherapy was observed in 58 (18.7%) patients. Abnormal baseline MNA (odds ratio (OR) = 1.87, p = 0.021) and MMSE (OR = 2.58, p = 0.022) were independent predictive factors of MMSE impairment. These results suggest that pre-existing cognitive impairment and malnutrition are predictive factors for cognitive decline during chemotherapy in elderly cancer patients. Detection and management of these risk factors should be systematically considered in this population before starting chemotherapy.

28 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
GBGiulia Binarelli
Giulia Binarelli
MLMarie Lange
Marie Lange
MSMélanie Dos Santos
Mélanie Dos Santos
JGJean-Michel Grellard
Jean-Michel Grellard
ALANAIS LELAIDIER
ANAIS LELAIDIER
FJFlorence Joly
Florence Joly
Cancer-related cognitive impairment (CRCI) is a frequent side-effect of cancer treatment, with important consequences on patients’ quality of life. Cognitive stimulation and physical activity are the most efficient in improving cognitive impairment, but they are challenging to generalize in hospitals’ routine and to patients’ needs and schedules. Moreover, the added value of a combination of these interventions needs to be more investigated. The Cog-Stim study is an interventional study investigating the feasibility of a web-based multimodal intervention (combining cognitive stimulation and physical activity for the improvement of cognitive complaints among breast-cancer patients currently treated with radiotherapy (n = 20). Patients will take part in a 12-week program, proposing two sessions per week of web-based cognitive stimulation (20 min/session with HappyNeuron®) and two sessions per week of web-based physical activity (30 min/session with Mooven® platform). Cognitive complaints (FACT-Cog) and objective cognitive functioning (CNS Vital Signs®), anxiety, depression (HADS), sleep disorders (ISI) and fatigue (FACIT-Fatigue) will be assessed before and after the intervention. The primary endpoint is the adherence rate to the intervention program. Patients’ satisfaction, reasons for non-attrition and non-adherence to the program will also be assessed. The overall goal of this study is to collect information to develop web-based interventions for cognitive difficulties in supportive care units.

22 April 2026 in European Journal of Neurology
Verified
Journal Article
Open access
FSFlorian W. Sander
Florian W. Sander
MPMarie Pittet
Marie Pittet
VMValeria Manera
Valeria Manera
CKChristine Krebs
Christine Krebs
EBEsther Brill
Esther Brill
ASArseny Sokolov
Arseny Sokolov
Introduction: Cognitive complaints are often considered early indicators of Alzheimer's disease (AD) and commonly lead to memory clinic consultations. Prior studies suggest stronger associations between cognitive complaints and mood than with objective cognition, but this interplay remains poorly understood. Using a machine learning–supported approach, we aimed to (1) identify key predictors of cognitive complaints, and (2) compare the value of gamified versus standard neuropsychological testing in detecting subtle deficits. Methods: In this international multi‐center study, 98 participants (57 females; mean age 71.9, range 55–86) from three memory clinics completed the Cognitive Failures Questionnaire (CFQ), mood and apathy questionnaires, the tablet‐based gamified Adaptive Cognitive Evaluation Explorer (ACE‐X), and standard neuropsychological tests. Predictors of CFQ scores were examined using elastic net regression and the Boruta algorithm, followed by linear mixed‐effects modeling. Results: Greater mood symptoms were associated with more cognitive complaints, whereas increasing age was linked to fewer complaints. Study center accounted for additional variance. The final model explained a substantial proportion of variance (conditional R 2 = 0.48, marginal R 2 = 0.33). Participants had lower z‐scores on ACE‐X compared to standard testing, but neither predicted the severity of cognitive complaints. Discussion: Mood and age were main predictors of cognitive complaints in memory clinic patients. Although ACE‐X yielded lower normative scores than standard tests, neither cognitive measure was linked to complaints. These findings highlight the importance of systematically assessing mood, adopting personalized approaches when evaluating subjective and objective cognition, and the potential value of gamified assessments for screening populations at risk of AD.

8 April 2026
Verified
Thesis
Closed access
GBGiulia Binarelli
Giulia Binarelli
Interventions numériques pour améliorer les plaintes cognitives chez les patientes atteintes d'un cancer du sein : mise en œuvre, suivi et promotion du programme de recherche Cog-Stim: Les troubles cognitifs liés au cancer (CRCI) sont un effet secondaire fréquent qui peut avoir des implicationsimportantes sur la vie quotidienne des patients, leur travail et leur observance thérapeutique. De nombreuxpatients expriment le besoin d'interventions telles que l'entraînement cognitif et physique ainsi que lesoutien psychologique. Cependant, les CRCI restent relativement méconnus parmi les professionnels de lasanté, et l'accès aux interventions en pratique clinique est limité. Bien que les interventions digitales offrentdes promesses pour élargir l'accès aux interventions, leur acceptabilité et leur faisabilité, en particulier chezles patients plus âgés, nécessitent des études supplémentaires. Les interventions multimodales, offrent dessolutions potentielles avec une efficacité accrue. Néanmoins, leur faisabilité nécessite un examenapprofondi. L'objectif principal du projet de recherche Cog-Stim était d'implémenter des interventionsfaisables et efficaces afin de rendre la prise en charge des troubles cognitifs liés au cancer accessible à unpublic plus large. Nos résultats ont montré la faisabilité et l'efficacité d’une intervention digitale multimodale,combinant un entraînement cognitif et physique non simultané, chez des patientes atteintes de cancer dusein. De plus, nous avons établi la faisabilité de la mise en œuvre d'une intervention cognitive digitale chezdes patientes âgées atteintes de cancer du sein. Les deux études ont notamment souligné le rôle essentielde la supervision par un expert en tant que facilitateur pour des résultats d'intervention réussis. Pour mettreen œuvre ces interventions en pratique clinique, des considérations clés incluent la motivation des patients,les préférences en matière de format d'intervention (à domicile/sur place, supervisé/non supervisé) et laprésence de plaintes cognitives significatives. En résumé, la prise en charge des troubles cognitifs encancérologie nécessite une approche multidimensionnelle, intégrant diverses interventions et desconsidérations centrées sur le patient pour améliorer la qualité de vie des individus après le cancer.